Ribeiro RM - Search Results

1

The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.

McMyn NF, Varriale J, Fray EJ, Zitzmann C, MacLeod H, Lai J, Singhal A, Moskovljevic M, Garcia MA, Lopez BM, Hariharan V, Rhodehouse K, Lynn K, Tebas P, Mounzer K, Montaner LJ, Benko E, Kovacs C, Hoh R, Simonetti FR, Laird GM, Deeks SG, Ribeiro RM, Perelson AS, Siliciano RF, Siliciano JM. McMyn NF, et al. Among authors: ribeiro rm. J Clin Invest. 2023 Sep 1;133(17):e171554. doi: 10.1172/JCI171554. J Clin Invest. 2023. PMID: 37463049 Free PMC article.

2

Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.

Lewin SR, Ribeiro RM, Walters T, Lau GK, Bowden S, Locarnini S, Perelson AS. Lewin SR, et al. Among authors: ribeiro rm. Hepatology. 2001 Nov;34(5):1012-20. doi: 10.1053/jhep.2001.28509. Hepatology. 2001. PMID: 11679973

3

Modeling deuterated glucose labeling of T-lymphocytes.

Ribeiro RM, Mohri H, Ho DD, Perelson AS. Ribeiro RM, et al. Bull Math Biol. 2002 Mar;64(2):385-405. doi: 10.1006/bulm.2001.0282. Bull Math Biol. 2002. PMID: 11926122

4

Hepatitis B virus viral dynamics: effects of drug dose and baseline alanine aminotransferase.

Ribeiro RM, Perelson AS. Ribeiro RM, et al. J Hepatol. 2002 Aug;37(2):277-9. doi: 10.1016/s0168-8278(02)00210-6. J Hepatol. 2002. PMID: 12127436 Review. No abstract available.

5

Dynamics of hepatitis B virus infection.

Ribeiro RM, Lo A, Perelson AS. Ribeiro RM, et al. Microbes Infect. 2002 Jul;4(8):829-35. doi: 10.1016/s1286-4579(02)01603-9. Microbes Infect. 2002. PMID: 12270730 Free article. Review.

6

In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?

Ribeiro RM, Mohri H, Ho DD, Perelson AS. Ribeiro RM, et al. Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15572-7. doi: 10.1073/pnas.242358099. Epub 2002 Nov 14. Proc Natl Acad Sci U S A. 2002. PMID: 12434018 Free PMC article.

7

Dynamics of alanine aminotransferase during hepatitis C virus treatment.

Ribeiro RM, Layden-Almer J, Powers KA, Layden TJ, Perelson AS. Ribeiro RM, et al. Hepatology. 2003 Aug;38(2):509-17. doi: 10.1053/jhep.2003.50344. Hepatology. 2003. PMID: 12883496

8

Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b.

Powers KA, Dixit NM, Ribeiro RM, Golia P, Talal AH, Perelson AS. Powers KA, et al. Among authors: ribeiro rm. Semin Liver Dis. 2003;23 Suppl 1:13-8. doi: 10.1055/s-2003-41630. Semin Liver Dis. 2003. PMID: 12934163 Clinical Trial.

9

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection.

Torriani FJ, Ribeiro RM, Gilbert TL, Schrenk UM, Clauson M, Pacheco DM, Perelson AS. Torriani FJ, et al. Among authors: ribeiro rm. J Infect Dis. 2003 Nov 15;188(10):1498-507. doi: 10.1086/379255. Epub 2003 Nov 13. J Infect Dis. 2003. PMID: 14624375 Clinical Trial.

10

Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy.

Di Mascio M, Ribeiro RM, Markowitz M, Ho DD, Perelson AS. Di Mascio M, et al. Among authors: ribeiro rm. Math Biosci. 2004 Mar-Apr;188:47-62. doi: 10.1016/j.mbs.2003.08.003. Math Biosci. 2004. PMID: 14766093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page